Hydralazine is a medication that causes vasodilation on the arterioles which ultimately leads to a reduction in blood pressure. It isn’t a medication that is used terribly often and I will discuss the reasons for this as well as other hydralazine clinical pearls you...
Direct-acting oral anticoagulants (DOACs; also called NOACs – novel oral anticoagulants) are an increasingly popular alternative to warfarin. Meanwhile, the number of obese patients requiring anticoagulation is also increasing. Because the landmark studies that...
On a previous post, I discussed some issues surrounding digoxin use in CHF. In this post, I wanted to cover strategies for managing an out of range digoxin level. Digoxin is a drug that we can and do often assess drug levels. In clinical practice, checking levels for...
I’m extremely grateful for the many pharmacists who have stepped up and provided education on topics they are passionate about. I’ve touched on QT prolongation in the past, but Daniel Lieu, PharmD has taken it up a notch! He has provided some spot-on...
Digoxin is one of those medications that has a lot of unique clinical quirks. Here are a few clinical pearls you must remember when using digoxin in CHF. When using digoxin in CHF (more specifically (HFrEF) you must remember to check electrolytes. Alterations in...
Amiodarone is a medication that you need to pay attention to. It has numerous clinical quirks that can cause serious harm if one is not aware of them. Here’s a list of the amiodarone boxed warnings as well as some other clinical practice pearls. Amiodarone Boxed...
